Literature DB >> 9647260

Lymphocyte activation gene-3 (LAG-3) expression and IFN-gamma production are variably coregulated in different human T lymphocyte subpopulations.

E Scala1, M Carbonari, P Del Porto, M Cibati, T Tedesco, A M Mazzone, R Paganelli, M Fiorilli.   

Abstract

We evaluated the relationship between cytokine profile and the expression of the lymphocyte activation gene-3 (LAG-3) in both T cell clones and polyclonal T cell lines; LAG-3 is a CD4-like protein whose expression is reportedly restricted to Th1/0 cells and dependent upon IFN-gamma. We found that, while LAG-3 was expressed only by CD4+ T cell clones producing IFN-gamma, most CD8+ clones producing IL-4 but not IFN-gamma (i.e., with a T cytotoxic-2-like profile) were LAG-3+. The intensity of LAG-3 expression by CD8+ clones correlated with the amount of released IFN-gamma, suggesting that this cytokine is not required for expression but rather for the up-regulation of LAG-3. Flow cytometric analyses of polyclonal T cell lines confirmed that LAG-3 could be expressed by both CD4+ and CD8+ cells that did not contain cytoplasmic IFN-gamma. In these cell lines, large proportions of CD4+ and CD8+ cells coexpressed LAG-3 and CD30, a putative marker of Th2-like cells. Overall, our data do not support the earlier suggestion that LAG-3 and CD30 are selective markers of T cells with type-1 and type-2 cytokine profiles, respectively.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9647260

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Human T cells with a type-2 cytokine profile are resistant to apoptosis induced by primary activation: consequences for immunopathogenesis.

Authors:  M Carbonari; T Tedesco; P Del Porto; R Paganelli; M Fiorilli
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

Review 2.  Exploring the Mechanisms Underlying the Cardiotoxic Effects of Immune Checkpoint Inhibitor Therapies.

Authors:  Daniel Ronen; Aseel Bsoul; Michal Lotem; Suzan Abedat; Merav Yarkoni; Offer Amir; Rabea Asleh
Journal:  Vaccines (Basel)       Date:  2022-03-31

3.  Blockade or Deletion of IFNγ Reduces Macrophage Activation without Compromising CAR T-cell Function in Hematologic Malignancies.

Authors:  Stefanie R Bailey; Sonika Vatsa; Rebecca C Larson; Amanda A Bouffard; Irene Scarfò; Michael C Kann; Trisha R Berger; Mark B Leick; Marc Wehrli; Andrea Schmidts; Harrison Silva; Kevin A Lindell; Ashley Demato; Kathleen M E Gallagher; Matthew J Frigault; Marcela V Maus
Journal:  Blood Cancer Discov       Date:  2022-03-01

4.  Txk, a nonreceptor tyrosine kinase of the Tec family, is expressed in T helper type 1 cells and regulates interferon gamma production in human T lymphocytes.

Authors:  J Kashiwakura; N Suzuki; H Nagafuchi; M Takeno; Y Takeba; Y Shimoyama; T Sakane
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

5.  Depletion of LAG-3+ T Cells Translated to Pharmacology and Improvement in Psoriasis Disease Activity: A Phase I Randomized Study of mAb GSK2831781.

Authors:  Joanne Ellis; Daniel J B Marks; Naren Srinivasan; Christine Barrett; Thomas G Hopkins; Anna Richards; Rainard Fuhr; Muna Albayaty; Martin Coenen; Lia Liefaard; Karen Leavens; Katherine L Nevin; Shuo Tang; Stephen A Hughes; Léa Fortunato; Ken Edwards; Yi Cui; Rabia Anselm; Christopher J Delves; Emilie Charles; Maria Feeney; Thomas M Webb; Sara J Brett; Tim S Schmidt; John Stone; Caroline O S Savage; Nicolas Wisniacki; Ruth M Tarzi
Journal:  Clin Pharmacol Ther       Date:  2020-11-24       Impact factor: 6.875

6.  Modulation of redox balance leaves murine diabetogenic TH1 T cells "LAG-3-ing" behind.

Authors:  Meghan M Delmastro; Alexis J Styche; Massimo M Trucco; Creg J Workman; Dario A A Vignali; Jon D Piganelli
Journal:  Diabetes       Date:  2012-05-14       Impact factor: 9.461

7.  Cardiac morbidity in HIV infection is associated with checkpoint inhibitor LAG-3 on CD4 T cells.

Authors:  Suresh Pallikkuth; Rajendra Pahwa; Bagavathi Kausalya; Shanmugam Saravanan; Li Pan; R Vignesh; Syed Iqbal; Sunil S Solomon; Kailapuri G Murugavel; Selvamuthu Poongulali; Nagalingeswaran Kumarasamy; Savita Pahwa
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

8.  Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis.

Authors:  Stephanie M Slevin; Lucy C Garner; Conor Lahiff; Malcolm Tan; Lai Mun Wang; Helen Ferry; Borgel Greenaway; Kate Lynch; Alessandra Geremia; Stephen Hughes; Karen Leavens; David Krull; Daniel J B Marks; Katherine Nevin; Kevin Page; Naren Srinivasan; Ruth Tarzi; Paul Klenerman; Simon Travis; Carolina V Arancibia-Cárcamo; Satish Keshav
Journal:  J Crohns Colitis       Date:  2020-10-05       Impact factor: 9.071

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.